Shandong Shengli Corporation Limited is a comprehensive high-tech corporation integrated with R&D, production, and marketing, primarily focused on the Animal Health and Agro-chemical industries. With two manufacturing bases located in Jinan and Jining, both constructed according to GMP standards, the company boasts a yearly fermentation capacity of over 4000 tons. The main products of the corporation include Tiamulin Fumarate, Flavophospholipol, Monensin, Salinomycin, Enramycin, Avermectin, Avilamycin, and Natamycin. The Tiamulin Fumarate product has received the FDA VMF number 005-959 and the COS CEP number 2009-066.

Services include:
- Intermediates
- Fine Chemicals

Shandong Shengli Bioengineering is committed to delivering high-quality products and services to the pharmaceutical industry. For further information, please visit vicome.com.